Skip to main content
Top
Published in: International Urology and Nephrology 4/2017

Open Access 01-04-2017 | Nephrology - Original Paper

Relationship between plasma levels of zonulin, bacterial lipopolysaccharides, d-lactate and markers of inflammation in haemodialysis patients

Authors: Joanna Ficek, Katarzyna Wyskida, Rafał Ficek, Jarosław Wajda, Dariusz Klein, Joanna Witkowicz, Sylwia Rotkegel, Urszula Spiechowicz-Zatoń, Joanna Kocemba-Dyczek, Jarosław Ciepał, Andrzej Więcek, Magdalena Olszanecka-Glinianowicz, Jerzy Chudek

Published in: International Urology and Nephrology | Issue 4/2017

Login to get access

Abstract

Background

Increased permeability of the intestinal wall and intestinal dysbiosis may contribute to chronic systemic inflammation, one of the causes of accelerated atherosclerosis and cardiovascular morbidity and mortality burden in patients with chronic kidney disease. The aim of this study was to evaluate the association between markers of intestinal permeability and inflammation in haemodialysis (HD) patients.

Methods

Plasma concentration of zonulin, haptoglobin, TNFα, IL6, d-lactates and bacterial lipopolysaccharides (LPS) was assessed in blood samples obtained after overnight fast before midweek morning HD session in 150 stable, prevalent HD patients. Daily intake of energy and macronutrients was assessed on the basis of a food frequency questionnaire.

Results

Serum hsCRP level was increased in over 70% of patients. Plasma levels of zonulin [11.6 (10.9–12.3) vs 6.8 (5.8–7.8) ng/mL], IL6 [6.2 (1.0–10.3) vs 1.3 (1.0–2.0) pg/mL] and TNFα [5.9 (2.9–11.8) vs 1.6 (1.3–1.8) pg/mL], but not LPS and d-lactates were significantly higher in HD than in healthy controls. d-lactates and LPS levels were weakly associated with IL6 (R = 0.175; p = 0.03, and R = 0.241; p = 0.003). There was a borderline correlation between plasma zonulin and serum hsCRP (R = 0.159; p = 0.07), but not with IL6, LPS and d-lactates. In multiple regression, both serum CRP and plasma IL6 variability were explained by LPS (β = 0.143; p = 0.08 and β = 0.171; p = 0.04, respectively), only.

Conclusion

The weak association between plasma d-lactate, LPS and IL6 levels indicates that intestinal flora overgrowth or increased intestinal permeability contributes very slightly to the chronic inflammation development in HD patients.
Literature
1.
go back to reference Lindner A, Charra B, Sherrard DJ, Scribner BH (1974) Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290:697–701CrossRefPubMed Lindner A, Charra B, Sherrard DJ, Scribner BH (1974) Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290:697–701CrossRefPubMed
2.
go back to reference Wanner C, Zimmermann J, Schwedler S, Metzger T (2002) Inflammation and cardiovascular risk in dialysis patients. Kidney Int Suppl 80:99–102CrossRef Wanner C, Zimmermann J, Schwedler S, Metzger T (2002) Inflammation and cardiovascular risk in dialysis patients. Kidney Int Suppl 80:99–102CrossRef
3.
go back to reference Johnson RJ, Feehally J, Floege J (2014) Comprehensive clinical nephrology, 5th edn. Elsevier Health Sciences, Saunders, Amsterdam, pp 916–1029 Johnson RJ, Feehally J, Floege J (2014) Comprehensive clinical nephrology, 5th edn. Elsevier Health Sciences, Saunders, Amsterdam, pp 916–1029
4.
go back to reference Pecoits-Filho R, Bárány P, Lindholm B, Heimbürger O, Stenvinkel P (2002) Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17:1684–1688CrossRefPubMed Pecoits-Filho R, Bárány P, Lindholm B, Heimbürger O, Stenvinkel P (2002) Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17:1684–1688CrossRefPubMed
5.
go back to reference Gupta J, Mitra N, Kanetsky PA, Devaney J, Wing MR, Reilly M, Shah VO, Balakrishnan VS, Guzman NJ, Girndt M, Periera BG, Feldman HI, Kusek JW, Joffe MM, Raj DS; CRIC Study Investigators (2012) Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol 7:1938–1946CrossRef Gupta J, Mitra N, Kanetsky PA, Devaney J, Wing MR, Reilly M, Shah VO, Balakrishnan VS, Guzman NJ, Girndt M, Periera BG, Feldman HI, Kusek JW, Joffe MM, Raj DS; CRIC Study Investigators (2012) Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol 7:1938–1946CrossRef
6.
go back to reference Anders HJ, Andersen K, Stecher B (2013) The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int 83:1010–1016CrossRefPubMed Anders HJ, Andersen K, Stecher B (2013) The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int 83:1010–1016CrossRefPubMed
7.
go back to reference Żak-Gołąb A, Kocełak P, Aptekorz M, Zientara M, Juszczyk L, Martirosian G, Chudek J, Olszanecka-Glinianowicz M (2013) Gut microbiota, microinflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects. Int J Endocrinol 2013:674106. doi:10.1155/2013/674106 PubMedPubMedCentral Żak-Gołąb A, Kocełak P, Aptekorz M, Zientara M, Juszczyk L, Martirosian G, Chudek J, Olszanecka-Glinianowicz M (2013) Gut microbiota, microinflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects. Int J Endocrinol 2013:674106. doi:10.​1155/​2013/​674106 PubMedPubMedCentral
8.
go back to reference Delzenne NM, Neyrinck AM, Bäckhed F, Cani PD (2011) Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 7:639–646CrossRefPubMed Delzenne NM, Neyrinck AM, Bäckhed F, Cani PD (2011) Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 7:639–646CrossRefPubMed
9.
go back to reference Wirostko E, Johnson L, Wirostko B (1990) Ulcerative colitis associated chronic uveitis. Parasitization of intraocular leucocytes by mollicute-like organisms. J Submicrosc Cytol Pathol 22:231–239PubMed Wirostko E, Johnson L, Wirostko B (1990) Ulcerative colitis associated chronic uveitis. Parasitization of intraocular leucocytes by mollicute-like organisms. J Submicrosc Cytol Pathol 22:231–239PubMed
10.
go back to reference Wang F, Jiang H, Shi K, Ren Y, Zhang P, Cheng S (2012) Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients. Nephrology (Carlton) 17:733–738CrossRef Wang F, Jiang H, Shi K, Ren Y, Zhang P, Cheng S (2012) Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients. Nephrology (Carlton) 17:733–738CrossRef
11.
go back to reference Shi K, Wang F, Jiang H, Liu H, Wei M, Wang Z, Xie L (2014) Gut bacterial translocation may aggravate microinflammation in hemodialysis patients. Dig Dis Sci 59:2109–2117CrossRefPubMed Shi K, Wang F, Jiang H, Liu H, Wei M, Wang Z, Xie L (2014) Gut bacterial translocation may aggravate microinflammation in hemodialysis patients. Dig Dis Sci 59:2109–2117CrossRefPubMed
12.
go back to reference Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, Goldblum SE (2000) Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 355:1518–1519CrossRefPubMed Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, Goldblum SE (2000) Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 355:1518–1519CrossRefPubMed
13.
go back to reference Smecuol E, Sugai E, Niveloni S, Vázquez H, Pedreira S, Mazure R, Moreno ML, Label M, Mauriño E, Fasano A, Meddings J, Bai JC (2005) Permeability, zonulin production, and enteropathy in dermatitis herpetiformis. Clin Gastroenterol Hepatol 3:335–341CrossRefPubMed Smecuol E, Sugai E, Niveloni S, Vázquez H, Pedreira S, Mazure R, Moreno ML, Label M, Mauriño E, Fasano A, Meddings J, Bai JC (2005) Permeability, zonulin production, and enteropathy in dermatitis herpetiformis. Clin Gastroenterol Hepatol 3:335–341CrossRefPubMed
14.
go back to reference Klaus DA, Motal MC, Burger-Klepp U, Marschalek C, Schmidt EM, Lebherz-Eichinger D, Krenn CG, Roth GA (2013) Increased plasma zonulin in patients with sepsis. Biochem Med (Zagreb) 23:107–111CrossRef Klaus DA, Motal MC, Burger-Klepp U, Marschalek C, Schmidt EM, Lebherz-Eichinger D, Krenn CG, Roth GA (2013) Increased plasma zonulin in patients with sepsis. Biochem Med (Zagreb) 23:107–111CrossRef
15.
go back to reference Zhang D, Zhang L, Zheng Y, Yue F, Russell RD, Zeng Y (2014) Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients. Diabetes Res Clin Pract 106:312–318CrossRefPubMed Zhang D, Zhang L, Zheng Y, Yue F, Russell RD, Zeng Y (2014) Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients. Diabetes Res Clin Pract 106:312–318CrossRefPubMed
16.
go back to reference Pabijasz D, Grzybowska-Chlebowczyk U, Woś H (2013) Evaluation of intestinal permeability on the basis of zonulin levels, in children with inflammatory bowel disease. Post Nauk Med 5:346–350 Pabijasz D, Grzybowska-Chlebowczyk U, Woś H (2013) Evaluation of intestinal permeability on the basis of zonulin levels, in children with inflammatory bowel disease. Post Nauk Med 5:346–350
17.
go back to reference Ruan P, Gong ZJ, Zhang QR (2004) Changes of plasma d(-)-lactate, diamine oxidase and endotoxin in patients with liver cirrhosis. Hepatobiliary Pancreat Dis Int 3:58–61PubMed Ruan P, Gong ZJ, Zhang QR (2004) Changes of plasma d(-)-lactate, diamine oxidase and endotoxin in patients with liver cirrhosis. Hepatobiliary Pancreat Dis Int 3:58–61PubMed
18.
go back to reference Smith SM, Eng RH, Campos JM, Chmel H (1989) d-lactic acid measurements in the diagnosis of bacterial infections. J Clin Microbiol 27:385–388PubMedPubMedCentral Smith SM, Eng RH, Campos JM, Chmel H (1989) d-lactic acid measurements in the diagnosis of bacterial infections. J Clin Microbiol 27:385–388PubMedPubMedCentral
19.
go back to reference Kotanko P, Carter M, Levin NW (2006) Intestinal bacterial microflora—a potential source of chronic inflammation in patients with chronic kidney disease. Nephrol Dial Transplant 21:2057–2060CrossRefPubMed Kotanko P, Carter M, Levin NW (2006) Intestinal bacterial microflora—a potential source of chronic inflammation in patients with chronic kidney disease. Nephrol Dial Transplant 21:2057–2060CrossRefPubMed
20.
go back to reference Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C (1999) Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648–658CrossRefPubMed Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C (1999) Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648–658CrossRefPubMed
21.
go back to reference Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, Ni Z, Nguyen TH, Andersen GL (2013) Chronic kidney disease alters intestinal microbial flora. Kidney Int 83:308–315CrossRefPubMed Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, Ni Z, Nguyen TH, Andersen GL (2013) Chronic kidney disease alters intestinal microbial flora. Kidney Int 83:308–315CrossRefPubMed
22.
go back to reference Vaziri ND, Dure-Smith B, Miller R, Mirahmadi MK (1985) Pathology of gastrointestinal tract in chronic hemodialysis patients: an autopsy study of 78 cases. Am J Gastroenterol 80:608–611PubMed Vaziri ND, Dure-Smith B, Miller R, Mirahmadi MK (1985) Pathology of gastrointestinal tract in chronic hemodialysis patients: an autopsy study of 78 cases. Am J Gastroenterol 80:608–611PubMed
23.
go back to reference Ewaschuk JB, Naylor JM, Zello GA (2005) d-lactate in human and ruminant metabolism. J Nutr 135:1619–1625PubMed Ewaschuk JB, Naylor JM, Zello GA (2005) d-lactate in human and ruminant metabolism. J Nutr 135:1619–1625PubMed
Metadata
Title
Relationship between plasma levels of zonulin, bacterial lipopolysaccharides, d-lactate and markers of inflammation in haemodialysis patients
Authors
Joanna Ficek
Katarzyna Wyskida
Rafał Ficek
Jarosław Wajda
Dariusz Klein
Joanna Witkowicz
Sylwia Rotkegel
Urszula Spiechowicz-Zatoń
Joanna Kocemba-Dyczek
Jarosław Ciepał
Andrzej Więcek
Magdalena Olszanecka-Glinianowicz
Jerzy Chudek
Publication date
01-04-2017
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 4/2017
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1495-5

Other articles of this Issue 4/2017

International Urology and Nephrology 4/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.